{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2018"],"condition":["Cancer-Bowel-Back passage (rectum) or large bowel (colon)","Colorectal cancer with high risk features for peritoneal metastases","Surgery-Other surgery"],"disease":["Colorectal Cancer With High Risk Features For Peritoneal Metastases","Surgery-other Surgery","Cancer-bowel-back Passage (rectum) Or Large Bowel (colon)"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2466778"],"location":["Australia"],"study_start_month":["5"],"repository":["ECRIN MDR"],"study_status":["Not yet recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Relook Laparoscopy for Peritoneal Surface Disease (ReLaPSeD) TrialA prospective randomised controlled trial comparing  relook laparoscopy vs. standard follow-up for early detection and treatment of patients at high risk for peritoneal metastases after resection of colorectal cancer","description":"Interventions: Diagnostic laparoscopy refers to examination of the abdominal cavity through minimally-invasive (key-hole) surgery. It takes approximately 45 - 60 minutes and will be performed by a specialist colorectal surgeon.\nPatients randomised to the intervention group will undergo relook diagnostic laparoscopy at 9- 12 months post surgery (in addition to standard follow up tests, including clinical review, tumour markers and regular CT scans).\nPrimary outcome(s): To report and compare the 3-year overall survival in patients managed with relook laparoscopy vs. standard follow-up following curative resection for high risk colorectal cancer[3 years post-randomisation]\nStudy Design: Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Parallel;Type of endpoint: Safety/efficacy","dates":{"creation":"2018-05-15"},"accession":"2466778","cross_references":{"Australian New Zealand Clinical Trials Registry":["ACTRN12618000372280"]}}